Jim Simons Pharma Cyte Biotech, Inc. Transaction History
Renaissance Technologies LLC
- $63.4 Billion
- Q4 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Pharma Cyte Biotech, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 49,300 shares of PMCB stock, worth $80,359. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,300
Previous 49,700
0.8%
Holding current value
$80,359
Previous $94,000
19.15%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PMCB
# of Institutions
26Shares Held
916KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA192KShares$313,5900.0% of portfolio
-
Geode Capital Management, LLC Boston, MA165KShares$268,5190.0% of portfolio
-
Ayrton Capital LLC Westport, CT92.1KShares$150,1017.31% of portfolio
-
Equitec Proprietary Markets, LLC82.7KShares$134,8450.07% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA34.5KShares$56,2040.0% of portfolio
About PharmaCyte Biotech, Inc.
- Ticker PMCB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,750,100
- Market Cap $33.8M
- Description
- PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...